A group of investors, including Perceptive Advisors, Redmile Group, Alger and Hobart Healthcare, led a $136m round in Impulse Dynamics, a global medical device company. “This round of funding will accelerate our business, both commercially and with our pipeline of advanced technology innovation. We continue to make commercial progress globally with more than 9k heart failure patients implanted with CCM® therapy and millions more who can benefit. We are also getting closer to significantly impacting the implantable cardioverter defibrillator (ICD) market with successful enrollment in our INTEGRA-D clinical trial on the Optimizer® Integra CCM-D® System,” Jason Spees, Impulse Dynamics CEO.